Product image of Metformina Almus Pharma (Metformin Hydrochloride) supplied by GNH India

Metformina Almus Pharma

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Almus Pharma (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina Almus Pharma, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity, thereby lowering blood sugar levels.

GNH India supplies Metformina Almus Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Manufacturer / TM Owner

Almus Farmaceutica S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina Almus Pharma (metformin hydrochloride) is indicated for conditions within the type 2 diabetes mellitus therapeutic pathway.

  • Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

How It Works

  • Metformin hydrochloride acts primarily on the liver to inhibit gluconeogenesis, reducing hepatic glucose production. It also increases peripheral glucose uptake by enhancing insulin‑mediated activation of AMP‑activated protein kinase (AMPK), which improves insulin sensitivity in muscle and adipose tissue, leading to lower circulating glucose concentrations.

Side Effects

Metformina Almus Pharma may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools, especially at treatment initiation.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: life‑threatening accumulation of lactate, especially in renal impairment.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction: marked elevation of liver enzymes.
  • Hypoglycemia: when combined with other glucose‑lowering agents.
  • Anemia: rare reduction in red blood cell count.

Precautions & Warnings

Before initiating Metformina Almus Pharma, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Renal function: assess creatinine clearance and adjust dose in moderate impairment.
  • Hepatic disease: avoid use in severe liver dysfunction.
  • Lactic acidosis risk: contraindicated in conditions predisposing to hypoxia or reduced perfusion.
  • Elderly patients: start with lower dose and monitor tolerance.
  • Alcohol consumption: limit intake to reduce acidosis risk.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Metformina Almus Pharma can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis.
  • Cimetidine: can increase metformin plasma concentrations.
  • Alcohol binge drinking: heightens risk of lactic acidosis.
  • Certain antiretrovirals (e.g., didanosine): increase mitochondrial toxicity.
  • Diuretics that impair renal function: elevate metformin levels.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors/ARBs: monitor renal function and potassium.
  • Other antidiabetic agents: adjust dose to prevent hypoglycemia.
  • Thyroid hormones: may alter glucose metabolism.
  • Warfarin: monitor INR as metformin can affect anticoagulation control.

Frequently Asked Questions

Metformina Almus Pharma contains metformin hydrochloride and is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It helps lower both fasting and post‑prandial glucose levels by acting on the liver and peripheral tissues.

Metformin hydrochloride reduces hepatic glucose production and enhances insulin‑mediated glucose uptake in muscle and fat. It activates AMP‑activated protein kinase (AMPK), which improves cellular insulin sensitivity and decreases circulating glucose concentrations.

The dose of Metformina Almus Pharma is individualized by the prescribing clinician based on the patient’s renal function, glycemic targets, and tolerance. The prescriber determines the appropriate starting dose and any subsequent titration.

Safety of metformin during pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk, and the decision must be made by a qualified health‑care professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is generally first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia when used alone. Sulfonylureas, another common class, stimulate insulin release but can cause weight gain and higher hypoglycemia risk.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister or container. Protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Metformina Almus Pharma is taken orally as a tablet, usually with meals to reduce gastrointestinal discomfort. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed by a health‑care provider.

The most serious adverse events include lactic acidosis, a rare but potentially fatal condition, and severe skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if patients experience unexplained muscle pain, rapid breathing, abdominal discomfort, or skin eruptions.

Metformina Almus Pharma is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and known hypersensitivity to metformin or any excipients. Caution is also advised for those with hepatic disease or a history of lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT